Li Shurui didn’t hesitate. Faced with putting his life on hold indefinitely or the risk of catching COVID-19 by returning to university in the U.K., the 22-year-old business student decided to roll up his sleeve and receive an experimental coronavirus vaccine. Two injections made by Beijing Kexing Biological cost 2,000 rmb ($300) at the private Taihe Hospital in the Chinese capital.